Six weeks after STAT reported that Eli Lilly granted a single 79-year-old patient special access to...
Eli Lilly to allow more patients to apply for special access to unapproved obesity drug
Six weeks after STAT reported that Eli Lilly granted a single 79-year-old patient special access to retatrutide, an unapproved obesity drug,...
Author: STAT
Read Original Article